Privatbank M.M. Warburg suggests seven German stocks that hold significant growth prospects for forthcoming weeks
The private banking firm M.M. Warburg has added several German stocks to its monthly conviction list for October, including ATOSS, Puma, Kion Group, Grenke, Deutz, and Redcare Pharmacy. The bank sees a significant potential for growth in these companies, driven by positive analyst recommendations and strong earnings prospects.
ATOSS, a workforce management software company, has been added to the list with a price target of 142 euros. The bank expects ATOSS to publish its third-quarter results on October 23, which are expected to confirm recent trends of double-digit revenue growth and high margins.
Puma, the sportswear giant, is another stock on the list, with a price target of 85 euros, as of late September. The bank anticipates currency-adjusted revenue growth to accelerate for Puma's third-quarter 2024 results. Despite the valuation of Puma not reflecting its growth shift, the bank sees a mega-upside potential of 130 percent in the Puma stock.
Kion Group, a leading supplier of industrial vehicles and services, is another stock recommended by M.M. Warburg for October. The specific reasons for the recommendations of each stock, apart from Traton, were not provided in the text.
Grenke, a provider of financial services, and Deutz, an industrial equipment manufacturer, are also on the list. No specific price targets were provided for these stocks.
Redcare Pharmacy, a healthcare services provider, completes the list of seven German stocks recommended by M.M. Warburg for October.
The bank also recommends the Traton stock for October, with a potential increase in financial targets and a positive surprise with its quarterly results at the end of October. The Traton stock has a price target of 50 euros, indicating a 75 percent upside potential.
M.M. Warburg's research reports, which are regularly updated, emphasize these companies' robust fundamentals and outlooks. The buy recommendations typically factor in expected earnings growth, improved margins, or successful strategic initiatives in their respective industries.
While the specific reasons for each of these companies’ expected rises were not directly provided in the publicly available summaries from M.M. Warburg research, the bank's analyses consider parameters such as earnings revisions, sector recovery, innovation pipeline, and valuation discounts relative to peers.
In summary, the anticipation of stock price increases is grounded in M.M. Warburg’s positive analyst assessments and buy ratings, driven by favorable financial outlooks and operational factors, although precise justifications per company have not been disclosed in the available materials.
[1] Source: M.M. Warburg Research Reports [2] Source: M.M. Warburg Monthly Conviction List for October 2021 [3] Source: M.M. Warburg Analyst Recommendations and Target Price Upgrades for October 2021
Read also:
- Developing a Sales Strategy: Methods, Sample Plans, and Templates for Sales Plans
- Events that transpired on the night of August 13, 2025.
- Manchester-based entrepreneur Amman Ahmed propelled an unusual venture to an 8-digit empire, without external financing. This is the story of how he crafted a groundbreaking genre in the world of animal-oriented media, one growl and rhythm at a time.
- Cooking Quantity of Beef Corresponds to Citizens' Salaries - Analysts Disclose
